Skip to content

Safety and Efficacy of Local bFGF Administration Combined with Optic Canal Decompression for Traumatic Optic Neuropathy

Safety and Efficacy of Local bFGF Administration Combined with Optic Canal Decompression for Traumatic Optic Neuropathy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121516
Enrollment
Unknown
Registered
2026-03-31
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traumatic optic neuropathy

Interventions

Experimental Group:Perform conventional Endoscopic Transnasal Optic Canal Decompression (ETOCD) including 180° bone removal and dural puncture, followed by minimally invasive transplantation of Gefu-C
Control Group:Perform identical conventional Endoscopic Transnasal Optic Canal Decompression (ETOCD), followed by transplantation of blank biological gelatin material at the lesion site as a control

Sponsors

Eye Hospital, Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Clinically diagnosed with optic neuropathy. According to the "Expert Consensus on Endoscopic Transnasal Optic Canal Decompression for Traumatic Optic Neuropathy in China (2016)", the diagnostic criteria for TON are as follows: Necessary conditions: (1) History of trauma to the skull, orbit, or maxillofacial region, especially the frontal or temporal areas; (2) Acute visual function impairment after injury, such as decreased vision or blindness, visual field defects, color vision disorders, etc., excluding causes from previous diseases. Supporting conditions: (1) Positive RAPD, with no intraocular abnormality causing RAPD; (2) F-VEP examination showing disappearance of visual waveform or prolonged P100 latency and reduced amplitude, with no severe retinal lesions observed. When one eye is affected or bilateral involvement is asymmetrical, the supporting condition (1) applies; when both eyes are affected similarly, supporting condition (2) applies. If both necessary conditions are present, TON can be diagnosed. 2. Within 3 months of injury; 3. Age between 8 and 50 years; 4. Single-eye injury; 5. Best-corrected visual acuity of the injured eye ranging from light perception to 20/200; 6. RNFL and GCC layer atrophy in the injured eye compared to the contralateral eye is less than or equal to 30%; 7. Corticosteroid shock therapy is ineffective; 8. The patient is conscious, expresses clearly, voluntarily participates in this study, and personally signs the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Combined with retinal or optic nerve avulsion; 2. Preoperative CTA vascular scan reveals definite or suspected abnormalities of the internal carotid artery or ophthalmic artery; 3. Presence of surgical contraindications, or preoperative indications of chronic sinus infection; 4. Suffering from other ocular diseases (including vitreous hemorrhage, glaucoma, or high myopia); 5. Opacity of refractive media; 6. History of diabetes mellitus; 7. Lack of capacity or limited capacity for informed consent; 8. Lack of civil capacity or limited civil capacity.

Design outcomes

Primary

MeasureTime frame
Best Corrected Visual Acuity (BCVA);

Secondary

MeasureTime frame
Visual Field;Flash visual evoked potential;Peripapillary RNFL thickness;Pattern visual evoked potential;Pattern electroretinogram;Evaluation of wound and local site conditions;

Countries

China

Contacts

Public ContactWu Wencan

Eye Hospital, Wenzhou Medical University

wuwencan@wmu.edu.cn+86 577 8807 5582

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026